GBT new logo.png
GBT présentera prochainement ses données à l’occasion du Congrès virtuel 2021 de l'Association européenne d'hématologie (EHA)
12 mai 2021 10h05 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Californie, 12 mai 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ : GBT) a annoncé aujourd'hui que six abstracts relatifs à son programme de...
GBT new logo.png
GBT kündigt Präsentation von Daten auf dem virtuellen Kongress der European Hematology Association (EHA) 2021 an
12 mai 2021 10h05 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Kalifornien, May 12, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) kündigte heute an, dass auf dem Virtuellen Kongress der European Hematology...
GBT new logo.png
GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress
12 mai 2021 10h00 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that six abstracts related to its sickle cell disease (SCD) programs...
GBT new logo.png
GBT Announces New Employment Inducement Grants
07 mai 2021 08h00 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 07, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on May 1, 2021, the compensation committee of GBT’s board of...
GBT new logo.png
GBT Announces Participation in Upcoming Investor Conferences
06 mai 2021 08h00 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in virtual fireside chats at the following...
GBT new logo.png
GBT Reports First Quarter 2021 Financial Results
05 mai 2021 16h05 HE | Global Blood Therapeutics, Inc.
Achieved Oxbryta® (voxelotor) net revenues of $39.0 million; on track with plans to potentially expand access to Oxbryta in the U.S. and Europe      Advanced pipeline programs inclacumab and...
GBT new logo.png
GBT and Sickle Cell Disease Association of America Kick Off “Lift Every Voice to Shine the Light on Sickle Cell” Spoken Word Contest in Honor of World Sickle Cell Day 2021
04 mai 2021 08h00 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif. and HANOVER, Md., May 04, 2021 (GLOBE NEWSWIRE) -- In recognition of World Sickle Cell Day, which falls on June 19, 2021, Global Blood Therapeutics, Inc. (GBT) (NASDAQ:...
GBT new logo.png
GBT to Announce First Quarter 2021 Financial Results on Wednesday, May 5, 2021
28 avr. 2021 07h00 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will report first quarter 2021 financial results on...
GBT new logo.png
Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients
08 avr. 2021 03h00 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced The Lancet Haematology has published the complete analysis of...
GBT new logo.png
GBT Announces New Employment Inducement Grants
05 avr. 2021 08h00 HE | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on April 1, 2021, the compensation committee of GBT’s board...